Figure 1: Global Gene Panel Market Share (%) Analysis, By Technique, 2021
The increasing burden of chronic diseases is the major factor that is expected to drive the market growth of gene panel over the forecast period.
The rising burden of chronic diseases which are associated with genes such as stroke, heart attack, cancer, arthritis, and others are expected to drive growth of gene panel market over the forecast period. According to the data provided by the International Agency for Research on Cancer (IRAC) in 2018, it is estimated that there will be more than 27.5 million new cancer cases by 2040, which would be majorly due to factors such as unhealthy lifestyle, smoking, and reduced physical activities. Also, according to the statistics provided by the World Health Organization in 2018, over 795,000 people have stroke each year in the U.S. This is expected to create opportunities for gene panel market as a clinical diagnostic tool.
The rising number of product launch and approval is expected to drive the growth of the global gene panel market over the forecast period. For instance, in September 2020, Bionano Genomics, an American genomic diagnostics manufacturer, announced the launch of EpiPanelDx PLUS, which is a gene panel test for diagnosis of epilepsy.
Gene Panel Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients